ARCHIVES

In Brief: FDA Cool To Committee Review of INDs; New Commissioner Is Donald Kennedy, Of Stanford

This article is from The Cancer Letter archive.

Vol. 03 No. 10 | March 11, 1977

Download PDF Visit The Full Archive

Related Articles

Bevacizumab Prolongs Survival In Patients With Advanced Colorectal Cancer

November 26, 2004

Clinical Trials Approved by NCI CTEP Last Month

August 26, 2011

Move Starts To Strip Anticancer Drug Regulation From FDA After New Charges It Is Delaying INDs

October 15, 1976

Genentech’s Ferrara Selected for GM Award.

June 23, 2006

Source Identified for Hepatitis A Contamination of LAK-IL-2 Trials; Six MIs Seen; Rosenberg Updates Intramural Results

October 24, 1986

Cancer Act Doesn’t Require Geographic Distribution Of Comp Centers

March 4, 1977